IP Verse

Chengdu Kanghong Biotechnology Co., Ltd. et al. v. Regeneron Pharmaceuticals, Inc. - IPR2021-00402

Explore the PTAB proceeding IPR2021-00402 filed by Chengdu Kanghong Biotechnology Co., Ltd. et al. against Regeneron Pharmaceuticals, Inc. on Jan 7, 2021. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2021-00402
Filing Date
Jan 7, 2021
Petitioner
Chengdu Kanghong Biotechnology Co., Ltd. et al.
Respondent
Regeneron Pharmaceuticals, Inc.
Status
Terminated
Respondent Application Number
16159269
Respondent Tech Center
1600
Respondent Patent Number
10464992
Termination Date
Jun 25, 2021

Decision Documents New

Decision pending - set alert to receive updates

Counsels Involved New

Details of counsels involved in proceeding number IPR2021-00402.

TypeName
Petitioner CounselMatthew I. Kreeger
Respondent CounselDeborah Fishman

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.